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Infertility treatment for HIV-infected serodiscordant infertile 
couples is controversial and has ethical implications.  Eighty-six 
per cent of all HIV-infected individuals fall into the age group 
15 - 44 years.1 
Fifteen years ago HIV/AIDS was associated with short 
survival. However, the advent and effective use of highly 
active antiretroviral therapy (HAART) has led to a dramatic 
improvement in the health and life expectancy of HIV- infected 
individuals. Currently the life expectancy of such an individual 
is estimated at 20 years from the time of diagnosis.2
 In developed countries HIV-infected people can therefore 
lead relatively normal lives. However, in developing countries 
such as South Africa the disease is still often fatal due to pov-
erty, ignorance and lack of access to antiretroviral drugs. 
As the prevalence of HIV increases, gynaecologists will more 
often be faced with the issue of infertility treatment for HIV-
serodiscordant couples.
Background 
In 1990 the Centers for Disease Control (CDC) issued recom-
mendations against reproductive assistance in HIV-serodis-
cordant couples.3 In February 2002 the American Society of 
Reproductive Medicine (ASRM) published revised guidelines 
stating that HIV-serodiscordant couples may seek reproductive 
assistance.4 However, to date there are no definite guidelines on 
infertility treatment when both partners are infected with HIV. 
In these cases, the couple should be thoroughly counselled and 
treatment should be individualised.4 
In the period 1990 - 2002, European physicians performed 
3 000 inseminations in HIV-discordant couples without a single 
case of seroconversion.3 A review of world data on assisted 
reproduction techniques in HIV-serodiscordant couples showed 
that 1 370 patients had undergone 3 397 cycles of treatment 
without a single case of infection.3 Assisted reproduction tech-
niques could therefore definitely be indicated in HIV-
serodiscordant couples.
HIV and infertility
HIV infection per se can impact on both the female and male 
partner, thus affecting fertility. The HIV-positive woman can 
present with menstrual irregularities (in 20% of cases), an in-
creased incidence of sexually transmitted infections and pelvic 
inflammatory disease, and a decreased pregnancy rate.5
The HIV-positive man can present with hypogonadism, 
testicular germ cell loss, testicular atrophy and reduced semen 
parameters.5
Ethical concerns
The four basic principles of ethics, namely autonomy, benefi-
cence, non-maleficence and justice, must always be adhered to 
when dealing with HIV-discordant couples.6 However, these 
principles often need to be addressed individually and not in 
combination. Pre-conceptual counselling is vital and informed 
consent mandatory at all times.  
Two major ethical concerns are the welfare of the offspring 
and the avoidance of seroconversion of the uninfected partner.2
The welfare of the offspring
The risk of mother-to-child transmission is of utmost impor-
tance. Without any intervention the risk of transmission is 13 - 
30%.7 HAART during pregnancy and labour, elective caesarean 
section, no breastfeeding and administration of antiretroviral 
drugs to the neonate reduces the risk of vertical transmission to 
less than 2%.8 Zidovudine (AZT) on its own during pregnancy 
or labour has been found to lower transmission rates by 5%.9 
In HIV-infected individuals the issue of uncertain prognosis 
always needs to be kept in mind.2 When a pregnancy is being 
considered, the concern is whether it would be in the best inter-
ests of the child to be born to a parent, or parents, who may not 
be available for long-term childrearing.4 However, advances in 
medical management have resulted in an improvement in life 
expectancy and quality of life of infected individuals.4 It would 
therefore be ethically unjustifiable to deny these couples fertility 
treatment.2 
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Infertility treatment of the HIV-
serodiscordant couple 
The rate of HIV transmission has been estimated to be 1 in 
500 - 1 000 acts of unprotected intercourse.10 The rate of transfer 
from man to woman is 0.15% and from woman to man 0.09%.11 
The risk is also influenced by viral load, degree of virulence 
and stage of disease.11 Unprotected sexual intercourse should be 
avoided at all times.
Pre-conceptual counselling is mandatory when treating HIV-
serodiscordant couples. It aims at discussing all the reproduc-
tive options available to them, HAART therapy and its benefits, 
treatment failure, risk of vertical transmission, their long-term 
health outcome and the support network that should be in 
place.12 However, no treatment option is 100% risk free, and 
this should be emphasised during pre-conceptual counselling. 
Alternative options available are adoption or, in the case of 
an HIV-positive man, the use of donor sperm. These options 
should also be discussed with the couple. A multidisciplinary 
team approach will further facilitate the management of these 
couples.4
Treatment should be individualised depending on which 
partner is infected with HIV and the underlying cause of the 
infertility. Both partners should undergo full sexual health 
screening to ensure that any coexisting infections are diagnosed 
and treated before fertility treatment commences.12 All appropri-
ate laboratory investigations should be performed during this 
health screen. A male and female fertility screen should be done, 
as the findings will impact on the type of fertility treatment to 
be performed.12 
Two scenarios are possible with regard to HIV status in 
a discordant couple: positive female partner and negative 
male partner and negative female partner and positive male 
partner.
In the case of a positive female partner and a negative male 
partner, two treatment options are available. With anovulation, 
moderate male factor infertility and unexplained infertility, 
intrauterine insemination (IUI) should be performed.12 How-
ever, with tubal factor infertility, severe male factor and failed 
inseminations, in vitro fertilisation (IVF) or intracytoplasmic 
sperm injection (ICSI) is necessary.12 
In the case of a positive male partner and a negative female 
partner, two treatment options are available. If there is no tubal 
pathology and the results of semen analysis are normal, sperm 
washing should be done with IUI or IVF.12 However, with tubal 
occlusion and severe male factor infertility, sperm washing 
coupled with IVF/ICSI should be performed.12 
Semen preparation – laboratory aspects 
Semprini and co-workers originally proposed the semen 
preparation technique12 in which HIV-infected leucocytes in the 
semen are removed from the motile sperm by gradient centrifu-
gation in combination with ‘swim-up’. In short, the semen is 
centrifuged (15 - 18 minutes at 400 g) through a three-layer (45% 
– 70% – 90%) discontinuous colloidal silica density gradient.  
The clean sperm pellet at the bottom of the tube is carefully 
removed, resuspended in fresh sperm washing medium and 
centrifuged (10 minutes at 400 g) twice more.  After the second 
wash the supernatant is carefully removed and 0.5 ml fresh 
sperm washing medium is placed on the pellet. The live sperm 
are allowed to swim out of the pellet for approximately 1 hour.  
After this the supernatant with the live sperm is removed and 
used for IUI.
Although most research has confirmed the existence of HIV-1 
in association with cell-free seminal plasma (Liuzzi et al.,13 
reviewed in Vernazza et al.14), HIV-1 has also been demonstrated 
within spermatozoa by electron microscopy,15 and either HIV-1 
DNA or RNA in spermatozoan preparations has also been de-
tected.16 However, these cells have generally been reported to be 
negative for HIV-1 RNA or proviral DNA.17-19  In HIV-1-infected 
men the viral load in semen and blood decreases markedly after 
the initiation of HAART.20,21
According to Marina et al.,22 the possibility that the sample 
will contain detectable HIV after processing through a dis-
continuous gradient and a subsequent swim-up is extremely 
low, and the risk of HIV-1 transmission is therefore negligible.  
Although the virus has rarely been directly detected on sperma-
tozoa, even when HIV-RNA reverse transcriptase-polymerase 
chain reaction (RT-PCR) was used to screen specimens before 
IUI, Sauer and Chang23 found that small numbers of virus 
particles might go undetected.  It is therefore imperative that 
couples be informed that although the infection risk may be 
reduced with assisted reproductive technologies, it cannot be 
excluded altogether.
Using the above technique of semen preparation for serodis-
cordant couples, Semprini et al.1 reported over 2 000 intrauterine 
inseminations and more than 100 ICSI/IVF-ET cycles without 
seroconversion of the partner or infection of the baby. 
Occupational exposure and cross-contamination 
Strict universal precautions should be practised in all infertil-
ity laboratories. A separate laboratory area for HIV-infected 
patients would be ideal, but owing to financial constraints this 
is not always feasible. However, it is essential that all physicians 
and clinics treating seropositive patients have adequate knowl-
edge and resources to deal with these circumstances.
Conclusion
The demand for risk-reduction fertility treatment in HIV-dis-
cordant couples is rising. Timed unprotected intercourse is an 
unacceptable practice. Sperm washing is an ideal treatment 
option when the male partner is HIV positive.
Pre-conceptual counselling and informed consent are essen-
tial. Ethical aspects should always be individualised. HAART 
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and elective caesarean section decrease the rate of vertical 
transmission. However, the safe interventions available today 
mean that it is mandatory to provide infertility treatment when 
the HIV-discordant couple requests it.
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Diabetes is the most common cause of blindness 
in the working age population of developed 
countries. Retinopathy may be present in over 
95% of people who have had type 1 diabetes 
for 20 years or more. Screening leads to 
effective treatment and preservation of sight. 
The organization of effective, efficient screening 
programmes is vital, as recognised in the National 
Service Framework for Diabetes in the UK.
This book, a successor to the highly popular 
Practical Guide to Polaroid Retinal Photography, 
describes the essential components of a 
retinopathy screening programme, including 
the criteria for referral to an ophthalmologist, 
drawing upon the experience of the Newcastle 
system over the last two decades and the 
National Screening Committee Report upon Eye 
screening. It is fully illustrated, featuring a new 
set of 50 digital photographs, showing the normal 
retina and problems associated with diabetes, 
with explanatory text.
This conveniently sized handbook will be essential 
reading for all those involved in retinal screening, 
including optometrists, ophthalmologists, 
diabetologists and also medical students.
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